{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T18:27:20Z","timestamp":1795199240005,"version":"4.10.3"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001862","name":"Svenska Forskningsr\u00e5det Formas","doi-asserted-by":"publisher","award":["2017-04641, 2019-02433"],"award-info":[{"award-number":["2017-04641, 2019-02433"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DA047325"],"award-info":[{"award-number":["DA047325"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["I-1812"],"award-info":[{"award-number":["I-1812"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    \u03b3-Aminobutyric acid type A (GABA\n                    <jats:sub>A<\/jats:sub>\n                    ) receptors are pentameric ligand-gated ion channels abundant in the central nervous system and are prolific drug targets for treating anxiety, sleep disorders and epilepsy. Diverse small molecules exert a spectrum of effects on \u03b3-aminobutyric acid type A (GABA\n                    <jats:sub>A<\/jats:sub>\n                    ) receptors by acting at the classical benzodiazepine site. They can potentiate the response to GABA, attenuate channel activity, or counteract modulation by other ligands. Structural mechanisms underlying the actions of these drugs are not fully understood. Here we present two high-resolution structures of GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptors in complex with zolpidem, a positive allosteric modulator and heavily prescribed hypnotic, and DMCM, a negative allosteric modulator with convulsant and anxiogenic properties. These two drugs share the extracellular benzodiazepine site at the \u03b1\/\u03b3 subunit interface and two transmembrane sites at \u03b2\/\u03b1 interfaces. Structural analyses reveal a basis for the subtype selectivity of zolpidem that underlies its clinical success. Molecular dynamics simulations provide insight into how DMCM switches from a negative to a positive modulator as a function of binding site occupancy. Together, these findings expand our understanding of how GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptor allosteric modulators acting through a common site can have diverging activities.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-32212-4","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T01:02:55Z","timestamp":1659747775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Structural and dynamic mechanisms of GABAA receptor modulators with opposing activities"],"prefix":"10.1038","volume":"13","author":[{"given":"Shaotong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-3378","authenticated-orcid":false,"given":"Rebecca J.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-2794","authenticated-orcid":false,"given":"Erik","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-1147","authenticated-orcid":false,"given":"Ryan E.","family":"Hibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"key":"32212_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.neuron.2015.03.042","volume":"86","author":"S Braat","year":"2015","unstructured":"Braat, S. & Kooy, R. F. The GABAA receptor as a therapeutic target for neurodevelopmental disorders. Neuron 86, 1119\u20131130 (2015).","journal-title":"Neuron"},{"key":"32212_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1124\/jpet.117.244673","volume":"364","author":"SH Chuang","year":"2018","unstructured":"Chuang, S. H. & Reddy, D. S. Genetic and molecular regulation of extrasynaptic GABA-A receptors in the brain: Therapeutic insights for epilepsy. J. Pharm. Exp. Ther. 364, 180\u2013197 (2018).","journal-title":"J. Pharm. Exp. Ther."},{"key":"32212_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrn2370","volume":"9","author":"TC Jacob","year":"2008","unstructured":"Jacob, T. C., Moss, S. J. & Jurd, R. GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat. Rev. Neurosci. 9, 331\u2013343 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"32212_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","volume":"54","author":"U Rudolph","year":"2014","unstructured":"Rudolph, U. & Mohler, H. GABAA receptor subtypes: therapeutic potential in down syndrome, affective disorders, schizophrenia, and autism. Annu Rev. Pharm. Toxicol. 54, 483\u2013507 (2014).","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"32212_CR5","doi-asserted-by":"publisher","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","volume":"287","author":"E Sigel","year":"2012","unstructured":"Sigel, E. & Steinmann, M. E. Structure, function, and modulation of GABA(A) receptors. J. Biol. Chem. 287, 40224\u201340231 (2012).","journal-title":"J. Biol. Chem."},{"key":"32212_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/pr.108.00505","volume":"60","author":"RW Olsen","year":"2008","unstructured":"Olsen, R. W. & Sieghart, W. International union of pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update Pharm. Rev. 60, 243\u2013260 (2008).","journal-title":"Update Pharm. Rev."},{"key":"32212_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","volume":"39","author":"E Sigel","year":"2018","unstructured":"Sigel, E. & Ernst, M. The benzodiazepine binding sites of GABAA receptors. Trends Pharm. Sci. 39, 659\u2013671 (2018).","journal-title":"Trends Pharm. Sci."},{"key":"32212_CR8","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/81800","volume":"3","author":"RJ Walters","year":"2000","unstructured":"Walters, R. J., Hadley, S. H., Morris, K. D. & Amin, J. Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms. Nat. Neurosci. 3, 1274\u20131281 (2000).","journal-title":"Nat. Neurosci."},{"key":"32212_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.neuropharm.2015.04.027","volume":"95","author":"SJ Middendorp","year":"2015","unstructured":"Middendorp, S. J., Maldifassi, M. C., Baur, R. & Sigel, E. Positive modulation of synaptic and extrasynaptic GABAA receptors by an antagonist of the high affinity benzodiazepine binding site. Neuropharmacology 95, 459\u2013467 (2015).","journal-title":"Neuropharmacology"},{"key":"32212_CR10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.tibs.2021.01.011","volume":"46","author":"JJ Kim","year":"2021","unstructured":"Kim, J. J. & Hibbs, R. E. Direct structural insights into GABAA receptor pharmacology. Trends Biochem Sci. 46, 502\u2013517 (2021).","journal-title":"Trends Biochem Sci."},{"key":"32212_CR11","first-page":"517","volume":"76","author":"K Ramakrishnan","year":"2007","unstructured":"Ramakrishnan, K. & Scheid, D. C. Treatment options for insomnia. Am. Fam. Physician 76, 517\u2013526 (2007).","journal-title":"Am. Fam. Physician"},{"key":"32212_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0922-4106(93)90043-9","volume":"246","author":"C Faure-Halley","year":"1993","unstructured":"Faure-Halley, C., Graham, D., Arbilla, S. & Langer, S. Z. Expression and properties of recombinant alpha 1 beta 2 gamma 2 and alpha 5 beta 2 gamma 2 forms of the rat GABAA receptor. Eur. J. Pharm. 246, 283\u2013287 (1993).","journal-title":"Eur. J. Pharm."},{"key":"32212_CR13","first-page":"181","volume":"47","author":"W Sieghart","year":"1995","unstructured":"Sieghart, W. Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharm. Rev. 47, 181\u2013234 (1995).","journal-title":"Pharm. Rev."},{"key":"32212_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.01.036","volume":"136","author":"RW Olsen","year":"2018","unstructured":"Olsen, R. W. GABAA receptor: Positive and negative allosteric modulators. Neuropharmacology 136, 10\u201322 (2018).","journal-title":"Neuropharmacology"},{"key":"32212_CR15","first-page":"965","volume":"48","author":"A Stevenson","year":"1995","unstructured":"Stevenson, A., Wingrove, P. B., Whiting, P. J. & Wafford, K. A. beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site. Mol. Pharm. 48, 965\u2013969 (1995).","journal-title":"Mol. Pharm."},{"key":"32212_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0896-6273(90)90224-4","volume":"5","author":"E Sigel","year":"1990","unstructured":"Sigel, E., Baur, R., Trube, G., Mohler, H. & Malherbe, P. The effect of subunit composition of rat brain GABAA receptors on channel function. Neuron 5, 703\u2013711 (1990).","journal-title":"Neuron"},{"key":"32212_CR17","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1476-5381.1995.tb13310.x","volume":"114","author":"HK Im","year":"1995","unstructured":"Im, H. K., Im, W. B., Carter, D. B. & McKinley, D. D. Interaction of beta-carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors. Br. J. Pharm. 114, 1040\u20131044 (1995).","journal-title":"Br. J. Pharm."},{"key":"32212_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1476-5381.1989.tb14600.x","volume":"98","author":"T Yakushiji","year":"1989","unstructured":"Yakushiji, T., Fukuda, T., Oyama, Y. & Akaike, N. Effects of benzodiazepines and non-benzodiazepine compounds on the GABA-induced response in frog isolated sensory neurones. Br. J. Pharm. 98, 735\u2013740 (1989).","journal-title":"Br. J. Pharm."},{"key":"32212_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1523\/JNEUROSCI.08-01-00289.1988","volume":"8","author":"E Sigel","year":"1988","unstructured":"Sigel, E. & Baur, R. Allosteric modulation by benzodiazepine receptor ligands of the GABAA receptor channel expressed in Xenopus oocytes. J. Neurosci. 8, 289\u2013295 (1988).","journal-title":"J. Neurosci."},{"key":"32212_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-2654-5","volume":"585","author":"JJ Kim","year":"2020","unstructured":"Kim, J. J. et al. Shared structural mechanisms of general anaesthetics and benzodiazepines. Nature 585, 303\u2013308 (2020).","journal-title":"Nature"},{"key":"32212_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41586-018-0255-3","volume":"559","author":"S Zhu","year":"2018","unstructured":"Zhu, S. et al. Structure of a human synaptic GABAA receptor. Nature 559, 67\u201372 (2018).","journal-title":"Nature"},{"key":"32212_CR22","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41586-018-0833-4","volume":"565","author":"D Laverty","year":"2019","unstructured":"Laverty, D. et al. Cryo-EM structure of the human alpha1beta3gamma2 GABAA receptor in a lipid bilayer. Nature 565, 516\u2013520 (2019).","journal-title":"Nature"},{"key":"32212_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","volume":"565","author":"S Masiulis","year":"2019","unstructured":"Masiulis, S. et al. GABAA receptor signalling mechanisms revealed by structural pharmacology. Nature 565, 454\u2013459 (2019).","journal-title":"Nature"},{"key":"32212_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2165\/00003088-200443040-00002","volume":"43","author":"DR Drover","year":"2004","unstructured":"Drover, D. R. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clin. Pharmacokinet. 43, 227\u2013238 (2004).","journal-title":"Clin. Pharmacokinet."},{"key":"32212_CR25","first-page":"964","volume":"56","author":"AN Siriwardena","year":"2006","unstructured":"Siriwardena, A. N., Qureshi, Z., Gibson, S., Collier, S. & Latham, M. GPs\u2019 attitudes to benzodiazepine and \u2018Z-drug\u2019 prescribing: a barrier to implementation of evidence and guidance on hypnotics. Br. J. Gen. Pr. 56, 964\u2013967 (2006).","journal-title":"Br. J. Gen. Pr."},{"key":"32212_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep28674","volume":"6","author":"AT Che Has","year":"2016","unstructured":"Che Has, A. T. et al. Zolpidem is a potent stoichiometry-selective modulator of alpha1beta3 GABAA receptors: evidence of a novel benzodiazepine site in the alpha1-alpha1 interface. Sci. Rep. 6, 28674 (2016).","journal-title":"Sci. Rep."},{"key":"32212_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1124\/mol.110.069542","volume":"80","author":"EV Morlock","year":"2011","unstructured":"Morlock, E. V. & Czajkowski, C. Different residues in the GABAA receptor benzodiazepine binding pocket mediate benzodiazepine efficacy and binding. Mol. Pharm. 80, 14\u201322 (2011).","journal-title":"Mol. Pharm."},{"key":"32212_CR28","doi-asserted-by":"publisher","first-page":"11799","DOI":"10.1074\/jbc.272.18.11799","volume":"272","author":"A Buhr","year":"1997","unstructured":"Buhr, A., Baur, R. & Sigel, E. Subtle changes in residue 77 of the gamma subunit of alpha1beta2gamma2 GABAA receptors drastically alter the affinity for ligands of the benzodiazepine binding site. J. Biol. Chem. 272, 11799\u201311804 (1997).","journal-title":"J. Biol. Chem."},{"key":"32212_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/mol.52.4.676","volume":"52","author":"A Buhr","year":"1997","unstructured":"Buhr, A., Schaerer, M. T., Baur, R. & Sigel, E. Residues at positions 206 and 209 of the alpha1 subunit of gamma-aminobutyric AcidA receptors influence affinities for benzodiazepine binding site ligands. Mol. Pharm. 52, 676\u2013682 (1997).","journal-title":"Mol. Pharm."},{"key":"32212_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2165\/00023210-200418001-00004","volume":"18","author":"DJ Sanger","year":"2004","unstructured":"Sanger, D. J. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs 18, 9\u201315 (2004). discussion 41, 43-15.","journal-title":"CNS Drugs"},{"key":"32212_CR31","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1021\/jm00052a019","volume":"37","author":"HA Wieland","year":"1994","unstructured":"Wieland, H. A. & Luddens, H. Four amino acid exchanges convert a diazepam-insensitive, inverse agonist-preferring GABAA receptor into a diazepam-preferring GABAA receptor. J. Med Chem. 37, 4576\u20134580 (1994).","journal-title":"J. Med Chem."},{"key":"32212_CR32","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1111\/j.1471-4159.1990.tb01237.x","volume":"54","author":"DB Pritchett","year":"1990","unstructured":"Pritchett, D. B. & Seeburg, P. H. Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology. J. Neurochem 54, 1802\u20131804 (1990).","journal-title":"J. Neurochem"},{"key":"32212_CR33","first-page":"884","volume":"263","author":"J Benavides","year":"1992","unstructured":"Benavides, J., Peny, B., Durand, A., Arbilla, S. & Scatton, B. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system. J. Pharm. Exp. Ther. 263, 884\u2013896 (1992).","journal-title":"J. Pharm. Exp. Ther."},{"key":"32212_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coph.2005.10.003","volume":"6","author":"U Rudolph","year":"2006","unstructured":"Rudolph, U. & Mohler, H. GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr. Opin. Pharm. 6, 18\u201323 (2006).","journal-title":"Curr. Opin. Pharm."},{"key":"32212_CR35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tips.2012.08.003","volume":"33","author":"P Skolnick","year":"2012","unstructured":"Skolnick, P. Anxioselective anxiolytics: on a quest for the Holy Grail. Trends Pharm. Sci. 33, 611\u2013620 (2012).","journal-title":"Trends Pharm. Sci."},{"key":"32212_CR36","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1073\/pnas.89.4.1433","volume":"89","author":"A Herb","year":"1992","unstructured":"Herb, A. et al. The third gamma subunit of the gamma-aminobutyric acid type A receptor family. Proc. Natl Acad. Sci. USA 89, 1433\u20131437 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32212_CR37","doi-asserted-by":"publisher","first-page":"8824","DOI":"10.1073\/pnas.94.16.8824","volume":"94","author":"A Buhr","year":"1997","unstructured":"Buhr, A. & Sigel, E. A point mutation in the gamma2 subunit of gamma-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity. Proc. Natl Acad. Sci. USA 94, 8824\u20138829 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32212_CR38","first-page":"810","volume":"45","author":"H Luddens","year":"1994","unstructured":"Luddens, H., Seeburg, P. H. & Korpi, E. R. Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors. Mol. Pharm. 45, 810\u2013814 (1994).","journal-title":"Mol. Pharm."},{"key":"32212_CR39","doi-asserted-by":"publisher","first-page":"599812","DOI":"10.3389\/fnins.2020.599812","volume":"14","author":"G Richter","year":"2020","unstructured":"Richter, G., Liao, V. W. Y., Ahring, P. K. & Chebib, M. The Z-drugs zolpidem, zaleplon, and eszopiclone have varying actions on human GABA A receptors containing gamma1, gamma2, and gamma3 subunits. Front Neurosci. 14, 599812 (2020).","journal-title":"Front Neurosci."},{"key":"32212_CR40","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/S0021-9258(18)45961-3","volume":"267","author":"HA Wieland","year":"1992","unstructured":"Wieland, H. A., Luddens, H. & Seeburg, P. H. A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J. Biol. Chem. 267, 1426\u20131429 (1992).","journal-title":"J. Biol. Chem."},{"key":"32212_CR41","doi-asserted-by":"publisher","first-page":"13370","DOI":"10.1074\/jbc.274.19.13370","volume":"274","author":"S Renard","year":"1999","unstructured":"Renard, S. et al. Structural elements of the gamma-aminobutyric acid type A receptor conferring subtype selectivity for benzodiazepine site ligands. J. Biol. Chem. 274, 13370\u201313374 (1999).","journal-title":"J. Biol. Chem."},{"key":"32212_CR42","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1038\/s41596-020-0342-4","volume":"15","author":"S Raniolo","year":"2020","unstructured":"Raniolo, S. & Limongelli, V. Ligand binding free-energy calculations with funnel metadynamics. Nat. Protoc. 15, 2837\u20132866 (2020).","journal-title":"Nat. Protoc."},{"key":"32212_CR43","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1073\/pnas.88.4.1421","volume":"88","author":"DB Pritchett","year":"1991","unstructured":"Pritchett, D. B. & Seeburg, P. H. gamma-Aminobutyric acid type A receptor point mutation increases the affinity of compounds for the benzodiazepine site. Proc. Natl Acad. Sci. USA 88, 1421\u20131425 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32212_CR44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0028-3908(02)00159-4","volume":"43","author":"F Crestani","year":"2002","unstructured":"Crestani, F., Assandri, R., Tauber, M., Martin, J. R. & Rudolph, U. Contribution of the alpha1-GABA(A) receptor subtype to the pharmacological actions of benzodiazepine site inverse agonists. Neuropharmacology 43, 679\u2013684 (2002).","journal-title":"Neuropharmacology"},{"key":"32212_CR45","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1523\/JNEUROSCI.19-12-04847.1999","volume":"19","author":"AJ Boileau","year":"1999","unstructured":"Boileau, A. J., Evers, A. R., Davis, A. F. & Czajkowski, C. Mapping the agonist binding site of the GABAA receptor: evidence for a beta-strand. J. Neurosci. 19, 4847\u20134854 (1999).","journal-title":"J. Neurosci."},{"key":"32212_CR46","doi-asserted-by":"publisher","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife https:\/\/doi.org\/10.7554\/eLife.42166 (2018).","DOI":"10.7554\/eLife.42166"},{"key":"32212_CR47","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/bph.12280","volume":"170","author":"AC May","year":"2013","unstructured":"May, A. C., Fleischer, W., Kletke, O., Haas, H. L. & Sergeeva, O. A. Benzodiazepine-site pharmacology on GABAA receptors in histaminergic neurons. Br. J. Pharm. 170, 222\u2013232 (2013).","journal-title":"Br. J. Pharm."},{"key":"32212_CR48","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.neuropharm.2004.11.007","volume":"48","author":"E Leppa","year":"2005","unstructured":"Leppa, E. et al. Agonistic effects of the beta-carboline DMCM revealed in GABA(A) receptor gamma 2 subunit F77I point-mutated mice. Neuropharmacology 48, 469\u2013478 (2005).","journal-title":"Neuropharmacology"},{"key":"32212_CR49","doi-asserted-by":"publisher","first-page":"E4158","DOI":"10.1073\/pnas.1617567114","volume":"114","author":"B Lev","year":"2017","unstructured":"Lev, B. et al. String method solution of the gating pathways for a pentameric ligand-gated ion channel. Proc. Natl Acad. Sci. USA 114, E4158\u2013E4167 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32212_CR50","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1073\/pnas.1314997111","volume":"111","author":"L Sauguet","year":"2014","unstructured":"Sauguet, L. et al. Crystal structures of a pentameric ligand-gated ion channel provide a mechanism for activation. Proc. Natl Acad. Sci. USA 111, 966\u2013971 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32212_CR51","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.neuron.2016.03.032","volume":"90","author":"A Nemecz","year":"2016","unstructured":"Nemecz, A., Prevost, M. S., Menny, A. & Corringer, P. J. Emerging molecular mechanisms of signal transduction in pentameric ligand-gated ion channels. Neuron 90, 452\u2013470 (2016).","journal-title":"Neuron"},{"key":"32212_CR52","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.str.2016.03.004","volume":"24","author":"CL Morales-Perez","year":"2016","unstructured":"Morales-Perez, C. L., Noviello, C. M. & Hibbs, R. E. Manipulation of subunit stoichiometry in heteromeric membrane proteins. Structure 24, 797\u2013805 (2016).","journal-title":"Structure"},{"key":"32212_CR53","doi-asserted-by":"publisher","first-page":"e18556","DOI":"10.1371\/journal.pone.0018556","volume":"6","author":"JH Kim","year":"2011","unstructured":"Kim, J. H. et al. High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One 6, e18556 (2011).","journal-title":"PLoS One"},{"key":"32212_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/bs.mie.2017.06.035","volume":"594","author":"JA Lyons","year":"2017","unstructured":"Lyons, J. A., Boggild, A., Nissen, P. & Frauenfeld, J. Saposin-lipoprotein scaffolds for structure determination of membrane transporters. Methods Enzymol. 594, 85\u201399 (2017).","journal-title":"Methods Enzymol."},{"key":"32212_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"32212_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"32212_CR57","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s42003-019-0437-z","volume":"2","author":"T Wagner","year":"2019","unstructured":"Wagner, T. et al. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. 2, 218 (2019).","journal-title":"Commun. Biol."},{"key":"32212_CR58","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nmeth.2727","volume":"11","author":"A Kucukelbir","year":"2014","unstructured":"Kucukelbir, A., Sigworth, F. J. & Tagare, H. D. Quantifying the local resolution of cryo-EM density maps. Nat. Methods 11, 63\u201365 (2014).","journal-title":"Nat. Methods"},{"key":"32212_CR59","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J. Comput Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput Chem."},{"key":"32212_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"32212_CR61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D. Biol. Crystallogr 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"32212_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D. Biol. Crystallogr 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"32212_CR63","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model"},{"key":"32212_CR64","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0263-7855(97)00009-X","volume":"14","author":"OS Smart","year":"1996","unstructured":"Smart, O. S., Neduvelil, J. G., Wang, X., Wallace, B. A. & Sansom, M. S. HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J. Mol. Graph 14, 354\u2013360 (1996).","journal-title":"J. Mol. Graph"},{"key":"32212_CR65","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/nar\/gkn072","volume":"36","author":"J Pei","year":"2008","unstructured":"Pei, J., Kim, B. H. & Grishin, N. V. PROMALS3D: a tool for multiple protein sequence and structure alignments. Nucleic Acids Res 36, 2295\u20132300 (2008).","journal-title":"Nucleic Acids Res"},{"key":"32212_CR66","doi-asserted-by":"publisher","first-page":"e01456","DOI":"10.7554\/eLife.01456","volume":"2","author":"A Morin","year":"2013","unstructured":"Morin, A. et al. Collaboration gets the most out of software. Elife 2, e01456 (2013).","journal-title":"Elife"},{"key":"32212_CR67","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput Chem."},{"key":"32212_CR68","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"K Lindorff-Larsen","year":"2010","unstructured":"Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78, 1950\u20131958 (2010).","journal-title":"Proteins"},{"key":"32212_CR69","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1021\/ct300777p","volume":"9","author":"JP Jambeck","year":"2013","unstructured":"Jambeck, J. P. & Lyubartsev, A. P. Another piece of the membrane puzzle: extending slipids further. J. Chem. Theory Comput 9, 774\u2013784 (2013).","journal-title":"J. Chem. Theory Comput"},{"key":"32212_CR70","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput Chem. 25, 1157\u20131174 (2004).","journal-title":"J. Comput Chem."},{"key":"32212_CR71","doi-asserted-by":"publisher","unstructured":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001 (2015).","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"32212_CR72","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1021\/ct700200b","volume":"4","author":"B Hess","year":"2008","unstructured":"Hess, B. P-LINCS: a parallel linear constraint solver for molecular simulation. J. Chem. Theory Comput 4, 116\u2013122 (2008).","journal-title":"J. Chem. Theory Comput"},{"key":"32212_CR73","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello, M. & Rahman, A. Polymorphic transitions in single crystals: a new molecular dynamics method. J. Appl. Phys. 52, 7182\u20137190 (1981).","journal-title":"J. Appl. Phys."},{"key":"32212_CR74","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007).","journal-title":"J. Chem. Phys."},{"key":"32212_CR75","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/jcc.21787","volume":"32","author":"N Michaud-Agrawal","year":"2011","unstructured":"Michaud-Agrawal, N., Denning, E. J., Woolf, T. B. & Beckstein, O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J. Comput Chem. 32, 2319\u20132327 (2011).","journal-title":"J. Comput Chem."},{"key":"32212_CR76","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1021\/acs.jctc.6b00303","volume":"12","author":"F Comitani","year":"2016","unstructured":"Comitani, F., Limongelli, V. & Molteni, C. The free energy landscape of GABA binding to a pentameric ligand-gated ion channel and its disruption by mutations. J. Chem. Theory Comput. 12, 3398\u20133406 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"32212_CR77","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/jcc.21305","volume":"30","author":"M Bonomi","year":"2009","unstructured":"Bonomi, M., Barducci, A. & Parrinello, M. Reconstructing the equilibrium Boltzmann distribution from well-tempered metadynamics. J. Comput Chem. 30, 1615\u20131621 (2009).","journal-title":"J. Comput Chem."},{"key":"32212_CR78","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/35077011","volume":"411","author":"K Brejc","year":"2001","unstructured":"Brejc, K. et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411, 269\u2013276 (2001).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32212-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32212-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32212-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:20:10Z","timestamp":1669296010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32212-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["32212"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-32212-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742269680.793594707","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4582"}}